CLICK ACTIVATED PROTODRUGS AGAINST CANCER Trademark

Trademark Overview

On Saturday, October 31, 2020, a trademark application was filed for CLICK ACTIVATED PROTODRUGS AGAINST CANCER with the United States Patent and Trademark Office. The USPTO has given the CLICK ACTIVATED PROTODRUGS AGAINST CANCER trademark a serial number of 90976018. The federal status of this trademark filing is REGISTERED as of Tuesday, July 26, 2022. This trademark is owned by Shasqi, Inc.. The CLICK ACTIVATED PROTODRUGS AGAINST CANCER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing scientific research information in the field of pharmaceuticals
click activated protodrugs against cancer

General Information

Serial Number90976018
Word MarkCLICK ACTIVATED PROTODRUGS AGAINST CANCER
Filing DateSaturday, October 31, 2020
Status700 - REGISTERED
Status DateTuesday, July 26, 2022
Registration Number6805402
Registration DateTuesday, July 26, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding scientific research information in the field of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, December 27, 2020
Primary Code042
First Use Anywhere DateFriday, October 9, 2020
First Use In Commerce DateFriday, October 9, 2020

Trademark Owner History

Party NameShasqi, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 91407
Party NameShasqi, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 91407

Trademark Events

Event DateEvent Description
Tuesday, July 26, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 26, 2022REGISTERED-SUPPLEMENTAL REGISTER
Thursday, June 23, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 15, 2022APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, June 15, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, June 14, 2022USE AMENDMENT ACCEPTED
Wednesday, June 1, 2022AMENDMENT TO USE PROCESSING COMPLETE
Monday, October 18, 2021USE AMENDMENT FILED
Tuesday, May 3, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 16, 2021NON-FINAL ACTION E-MAILED
Thursday, December 16, 2021NON-FINAL ACTION WRITTEN
Thursday, November 18, 2021DIVISIONAL PROCESSING COMPLETE
Monday, October 18, 2021DIVISIONAL REQUEST RECEIVED
Wednesday, November 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 10, 2021ATTORNEY REVIEW COMPLETED
Monday, October 18, 2021TEAS REQUEST TO DIVIDE RECEIVED
Monday, October 18, 2021TEAS AMENDMENT OF USE RECEIVED
Wednesday, October 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 12, 2021ASSIGNED TO LIE
Tuesday, October 5, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 5, 2021NON-FINAL ACTION E-MAILED
Monday, April 5, 2021NON-FINAL ACTION WRITTEN
Monday, April 5, 2021ASSIGNED TO EXAMINER
Sunday, December 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, November 4, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

cancer against protodrugs activated click field pharmaceuticals information research scientific providing